Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is enriched with chromium and zinc
Targeted by Tirzepatide and Retatrutide
In the ACHIEVE-2 trial (Phase 3, 962 adults with type 2 diabetes on metformin), Orforglipron, a novel small-molecule oral GLP-1 RA went head-to-head against Dapagliflozin, one of the most widely used SGLT2 inhibitors
In the Phase 3 TRIUMPH-1 trial reported May 21, 2026, the 12 mg arm produced mean body-weight reduction of 28.3% at 80 weeks, with extension data reaching 30.3% at 104 weeks [1][2]
US$ 20.12
US$ 28.46
US$ 22.56
US$ 23.73
US$ 26.44
US$ 20.58
US$ 24.60
US$ 20.38
US$ 25.45
US$ 29.33
US$ 29.26
US$ 26.04
US$ 21.97
